Process View
A series of molecular signals initiated by a bile acid binding to an receptor located within a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "intracellular bile acid receptor signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| NCOR2 | nuclear receptor corepressor 2 | 1.000 | ||
| RXRA | retinoid X receptor, alpha | 1.000 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 1.000 | ||
| RARA | retinoic acid receptor, alpha | 1.000 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.999 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.999 | ||
| HR | hairless homolog (mouse) | 0.987 | ||
| ESR1 | estrogen receptor 1 | 0.918 | ||
| PGR | progesterone receptor | 0.891 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.776 | Human | |
| PPARA | peroxisome proliferator-activated receptor alpha | 0.648 | Human | |
| RUNX1 | runt-related transcription factor 1 | 0.643 | ||
| HDAC3 | histone deacetylase 3 | 0.578 | ||
| SKIL | SKI-like oncogene | 0.470 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.273 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.225 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.165 | Human | |
| HDAC4 | histone deacetylase 4 | 0.150 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.119 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.106 | ||
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.102 | ||
| HDAC5 | histone deacetylase 5 | 0.098 | ||
| PML | promyelocytic leukemia | 0.088 | ||
| SP1 | Sp1 transcription factor | 0.071 | ||
| THRB | thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian) | 0.060 | ||
| NR1H3 | nuclear receptor subfamily 1, group H, member 3 | 0.057 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.048 | ||
| HDAC7 | histone deacetylase 7 | 0.047 | ||
| PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.045 | ||
| EP300 | E1A binding protein p300 | 0.039 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.039 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.035 | ||
| SRF | serum response factor (c-fos serum response element-binding transcription factor) | 0.030 | ||
| CHD9 | chromodomain helicase DNA binding protein 9 | 0.029 | ||
| CCND3 | cyclin D3 | 0.026 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.025 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.022 | ||
| ATXN1L | ataxin 1-like | 0.021 | ||
| ACVR1B | activin A receptor, type IB | 0.019 | ||
| SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 | 0.018 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.018 | ||
| MED25 | mediator complex subunit 25 | 0.017 | ||
| PROX1 | prospero homeobox 1 | 0.017 | ||
| THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.016 | ||
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.014 | ||
| CXXC5 | CXXC finger protein 5 | 0.013 | ||
| NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | 0.013 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.012 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.012 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.012 | ||
| PRKD2 | protein kinase D2 | 0.011 | ||
| ESRRG | estrogen-related receptor gamma | 0.011 | ||
| TBL1X | transducin (beta)-like 1X-linked | 0.010 | ||
| SGK2 | serum/glucocorticoid regulated kinase 2 | 0.010 |